FR11C0033I2 - Correction de la contracture de dupuytren - Google Patents

Correction de la contracture de dupuytren

Info

Publication number
FR11C0033I2
FR11C0033I2 FR11C0033C FR11C0033C FR11C0033I2 FR 11C0033 I2 FR11C0033 I2 FR 11C0033I2 FR 11C0033 C FR11C0033 C FR 11C0033C FR 11C0033 C FR11C0033 C FR 11C0033C FR 11C0033 I2 FR11C0033 I2 FR 11C0033I2
Authority
FR
France
Prior art keywords
dupuytren
contracture
correction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR11C0033C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance Biofactures Corp
Original Assignee
Advance Biofactures Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Corp filed Critical Advance Biofactures Corp
Publication of FR11C0033I1 publication Critical patent/FR11C0033I1/fr
Application granted granted Critical
Publication of FR11C0033I2 publication Critical patent/FR11C0033I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
FR11C0033C 1997-03-27 2011-08-18 Correction de la contracture de dupuytren Active FR11C0033I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease
FR9803320A FR2772273B1 (fr) 1997-03-27 1998-03-18 Correction de la contracture de dupuytren

Publications (2)

Publication Number Publication Date
FR11C0033I1 FR11C0033I1 (fr) 2011-09-23
FR11C0033I2 true FR11C0033I2 (fr) 2012-03-16

Family

ID=25245473

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (fr) 1997-03-27 1998-03-18 Correction de la contracture de dupuytren
FR11C0033C Active FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (fr) 1997-03-27 1998-03-18 Correction de la contracture de dupuytren

Country Status (8)

Country Link
US (2) US6086872A (fr)
AU (1) AU733208B2 (fr)
DE (1) DE19813748A1 (fr)
DK (1) DK177324B1 (fr)
FR (2) FR2772273B1 (fr)
GB (1) GB2323530B (fr)
NO (1) NO981388L (fr)
SE (1) SE522723C2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
AU2006206393B2 (en) * 2005-01-21 2010-04-08 The Research Foundation Of State University Of New York Methods for treating adhesive capsulitis
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US20080233614A1 (en) * 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
WO2010102262A1 (fr) 2009-03-06 2010-09-10 Halozyme, Inc. Mutants thermosensibles de métalloprotéase matricielle 1 et leurs utilisations
US8702654B2 (en) 2009-03-25 2014-04-22 John M. Agee Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
DK2632446T3 (en) 2010-10-30 2019-04-01 Univ Oxford Innovation Ltd TREATMENT OF DUPUYTRY CONTRACT
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
JP6049714B2 (ja) 2011-07-20 2016-12-21 メディウンド リミテッド 結合組織疾患の治療のためのブロメライン由来タンパク質分解抽出物
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
EP4276180A3 (fr) 2012-01-12 2024-01-10 Endo Global Ventures Enzyme de clostridium histolyticum
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014107745A1 (fr) 2013-01-07 2014-07-10 Halozyme, Inc. Métalloprotéases matricielles mutantes sensibles aux métaux et leurs utilisations
AU2014228477B2 (en) 2013-03-15 2019-05-23 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
MX2019011574A (es) * 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
WO2021076618A1 (fr) 2019-10-15 2021-04-22 The Johns Hopkins University Traitement de fibromes utérins à l'aide de collagénase purifiée

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) * 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
FR2772273A1 (fr) 1999-06-18
NO981388L (no) 1998-09-28
NO981388D0 (no) 1998-03-26
DE19813748A1 (de) 1998-10-01
SE9800806D0 (sv) 1998-03-12
SE9800806L (sv) 1998-09-28
AU733208B2 (en) 2001-05-10
GB2323530B (en) 2001-10-10
GB2323530A (en) 1998-09-30
US6086872A (en) 2000-07-11
SE522723C2 (sv) 2004-03-02
GB9805050D0 (en) 1998-05-06
USRE39941E1 (en) 2007-12-18
FR11C0033I1 (fr) 2011-09-23
FR2772273B1 (fr) 2003-04-25
DK177324B1 (da) 2013-01-07
AU5966198A (en) 1998-10-01
DK40398A (da) 1998-09-28

Similar Documents

Publication Publication Date Title
FR11C0033I2 (fr) Correction de la contracture de dupuytren
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
BR9800705A (pt) Polimerização de ciclossiloxanos
DE69613368T2 (de) Chinazolin derivate
DE69613369T2 (de) Chinazolin derivate
DE69613367T2 (de) Chinazolin derivate
DE69536015D1 (de) Chinazolinone Derivate
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
PT907364E (pt) Composicao farmaceutica de libertacao sustida
PT868183E (pt) Formulacoes injectaveis de quinolona
PT1028718E (pt) Formulacao de libertacao prolongada
DK1300129T3 (da) Implantathætteglas
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
FI973229A0 (fi) Uusi farmaseuttinen koostumus
NO996545D0 (no) Behandling av aluminiumslagg
DE69805974T2 (de) 5-aroylnaphthalin derivate
DE69710305D1 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
KR970016291U (ko) 아령
FR2766727B1 (fr) Exerciseur
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
DE69804179D1 (de) Photoempfindliche Zusammensetzung
BR9708484A (pt) Aplicação de arilimidazóis substituídos
ID29414A (id) Pengobatan depresi
ID21264A (id) Peningkatan pci berdaya-guna tinggi
SE9704040D0 (sv) Dynamisk hantel